Your Health, We Care
In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.
Please keep all scheduled appointments with your doctor and the laboratory on time. Your doctor will conduct laboratory tests before treatment to determine whether your cancer is e···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：253
Pralsetinib may interfere with the efficacy of hormonal contraceptives (including birth control pills, patches, vaginal rings, implants, or injections). These should not be used as···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：271
Although severe adverse reactions to Pralsetinib (brand name: Gavreto) are relatively rare, the drug may still induce certain severe side effects, requiring close monitoring during···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：233
Pralsetinib is indicated for the treatment of adult patients with specific types of non-small cell lung cancer (NSCLC) that has metastasized to other parts of the body.What side ef···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：245
The efficacy of Pralsetinib was investigated in a multicenter, open-label, multi-cohort clinical trial (ARROW, NCT03037385).Is Pralsetinib Effective in Treatment?A total of 220 pat···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：223
Pralsetinib is the sixth drug under Genentech that has obtained FDA approval for the treatment of lung cancer.How Effective is Pralsetinib?The FDA has granted this drug Breakthroug···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：272
Please take pralsetinib strictly in accordance with the instructions of medical professionals.How to Take PralsetinibTake the medication once daily, with the dosage following the d···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：217
Pralsetinib, also known as GAVRETO, is a targeted therapy medication administered orally once daily. It is indicated for the treatment of certain cancers caused by abnormal RET gen···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：260
Pralsetinib is a tyrosine kinase inhibitor administered via oral route.Which Patients Are Suitable for Pralsetinib?Pralsetinib (trade name: Gavreto) is a pharmaceutical agent appro···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：213
Trabectedin (Yondelis) is a prescription medication indicated for the treatment of specific types of soft tissue sarcomas (e.g., liposarcoma and leiomyosarcoma) in patients who hav···【more】
Article source：Captain MedicineRelease date：2026-01-16Recommended：207
On December 1, 2020, South San Francisco, California – Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) has approved Gavreto™ (pra···【more】
Article source：Captain MedicineRelease date：2026-01-15Recommended：230
On August 9, 2023, the U.S. Food and Drug Administration (FDA) approved pralsetinib (trade name: Gavreto, developed by Genentech) for regular use in adult patients with metastatic ···【more】
Article source：Captain MedicineRelease date：2026-01-15Recommended：205
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】
Recommended：[list:visits]2025-17-12
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】
Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】
Recommended：[list:visits]2026-06-08
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】
Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】
Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】
Recommended：[list:visits]2026-03-08
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】
Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】
Recommended：[list:visits]2026-30-07
Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More
Lucius Pharmaceutical Co., Ltd., was established in 2020 in Vientiane, the capital of Laos. It aims to offer safe, effective, and affordable medicines globally. With a factory spanning 25,000 square meters, the company manufactures 200+ generic drugs in diverse therapeutic fields.
Address: No.26 Thongmang village, Xaythany district, Vientiane Capital, Laos
E-mail:laoslucius@gmail.com
Name: Lucius
Telegram name: Vira
No.:0085253923643
Telegram name: Vira
No.:0085253923643
